Literature DB >> 17982641

Increased risk for oral cancer is associated with coagulation factor XIII but not with factor XII.

Eleftherios Vairaktaris1, Stavros Vassiliou, Christos Yapijakis, Sofia Spyridonidou, Antonis Vylliotis, Spyridoula Derka, Emeka Nkenke, Gregory Fourtounis, Friedrich W Neukam, Efstratios Patsouris.   

Abstract

In light of recently found contribution of factors associated with thrombosis and inflammation to carcinogenesis, we investigated the possible association of coagulation factors XII and XIII with increased risk for oral cancer. In DNA samples of patients with oral squamous cell carcinoma and healthy controls of comparable ethnicity, age and sex, we studied the C46T polymorphism in FXII gene which affects gene transcription and the V34L polymorphism in FXIII gene which affects enzyme activity resulting in alteration of the fibrin network structure. No significant differences were observed in genotype and mutant allele frequencies of the FXII C46T polymorphism between patients and healthy controls. On the contrary, the obtained data for FXIII V34L polymorphism revealed a significant frequency increase of the L allele, which results in thinner fibrin network, in the whole group of patients compared to controls (33.1 versus 22.2% respectively, Fischer value P=0.006). In addition, LL homozygotes had a 3-fold greater risk for developing oral cancer (OR 2.893, 95% CI 1.056-7.890), while in VL heterozygotes a 2-fold greater risk was observed (OR 1.868, 95% CI 1.126-3.101). Significantly increased frequency of L allele was also observed in sub-groups of patients without family history of thrombophilia or cancer, with and without tobacco abuse and with alcohol abuse (P<0.05). Interestingly, in comparison to controls only patients with early cancer stages I and II had significantly increased L alleles and not patients with advanced stages III and IV. These findings suggest that the presence of L allele is strongly associated with oral cancer generation but not with its progression and metastasis. In the presence of L allele, the fibrin network is composed of thinner fibers, is less porous and facilitates tumor stroma formation and therefore tumor cell proliferation. Nevertheless, this thinner and less porous fibrin network inhibits cell migration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982641

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Identification of mRNA Signature for Predicting Prognosis Risk of Rectal Adenocarcinoma.

Authors:  Linlin Jiang; Peng Wang; Mu Su; Lili Yang; Qingbo Wang
Journal:  Front Genet       Date:  2022-05-18       Impact factor: 4.772

Review 2.  Advances of Coagulation Factor XIII.

Authors:  Da-Yu Shi; Shu-Jie Wang
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

3.  Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer.

Authors:  Julien Peltier; Jean-Pierre Roperch; Stéphane Audebert; Jean-Paul Borg; Luc Camoin
Journal:  Clin Proteomics       Date:  2018-04-09       Impact factor: 3.988

4.  Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy.

Authors:  Zhiwen Luo; Xiao Chen; Yefan Zhang; Zhen Huang; Hong Zhao; Jianjun Zhao; Zhiyu Li; Jianguo Zhou; Jianmei Liu; Jianqiang Cai; Xinyu Bi
Journal:  Front Cell Dev Biol       Date:  2021-01-28

5.  Coagulation Factor XIII Subunit A Is a Biomarker for Curative Effects and Prognosis in Malignant Solid Tumors, Especially Non-small Cell Lung Cancer.

Authors:  Yujiao Luo; Bin Li; Ji Li; Yang Zhang; Mingyang Deng; Chunhong Hu; Wenzhe Yan; Zhiguang Zhou; Guangsen Zhang
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244

6.  Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer.

Authors:  Seung Heon Lee; In Bum Suh; Eun Joo Lee; Gyu Young Hur; Sung Yong Lee; Sang Yeub Lee; Chol Shin; Jae Jeong Shim; Kwang Ho In; Kyung Ho Kang; Se Hwa Yoo; Je Hyeong Kim
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

Review 7.  Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment.

Authors:  Lilla Paragh; Daniel Törőcsik
Journal:  Biomed Res Int       Date:  2017-08-15       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.